Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2016 199,045,026      
Beginning balance, value at Dec. 31, 2016 $ 199,045 $ 103,716,955 $ (105,274,000) $ (1,358,000)
Common stock issued on private sale of securities, shares 181,355      
Common stock issued on private sale of securities, value $ 181 37,819   38,000
Common stock issued on exercise of warrants, shares 4,863,754      
Common stock issued on exercise of warrants, value $ 4,864 391,136   396,000
Common stock issued on conversion of notes payable, shares 29,986,772      
Common stock issued on conversion of notes payable, value $ 29,987 1,498,013   1,528,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,469,000   1,469,000
Fair value of options and warrants issued as compensation   888,000   888,000
Net loss     (4,835,000) (4,835,000)
Ending balance, shares at Dec. 31, 2017 234,076,907      
Ending balance, value at Dec. 31, 2017 $ 234,077 108,000,923 (110,109,000) (1,874,000)
Common stock issued on exercise of warrants, shares 12,697,483      
Common stock issued on exercise of warrants, value $ 12,697 634,303   647,000
Common stock issued on conversion of notes payable, shares 9,299,125      
Common stock issued on conversion of notes payable, value $ 9,299 569,701   579,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,778,000   1,778,000
Fair value of options and warrants issued as compensation   435,000   435,000
Common stock issued for services, shares 50,000      
Common stock issued for services, value $ 50 11,950   12,000
Net loss     (3,059,000) (3,059,000)
Ending balance, shares at Dec. 31, 2018 256,123,515      
Ending balance, value at Dec. 31, 2018 $ 256,123 $ 111,429,877 $ (113,168,000) $ (1,482,000)